In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe treatment option and sustained efficacy, as shown in a first-in-human study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/allogeneic-cd19-car-nk-cell-therapy-may-be-new-chapter-2025a10010md?src=rss
Author :
Publish date : 2025-12-30 02:40:00
Copyright for syndicated content belongs to the linked Source.
